Works by Taher, Ali T.


Results: 165
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Autoerythrocyte sensitization(Gardner–Diamond) syndrome.

    Published in:
    European Journal of Haematology, 2000, v. 65, n. 2, p. 144, doi. 10.1034/j.1600-0609.2000.9C234.x
    By:
    • Uthman, Imad W.;
    • Moukarbel, George V.;
    • Salman, Salah M.;
    • Salem, Ziad M.;
    • Taher, Ali T.;
    • Khalil, Ismail M.
    Publication type:
    Article
    11
    12
    13
    14
    15

    2021 update on clinical trials in β‐thalassemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 11, p. 1518, doi. 10.1002/ajh.26316
    By:
    • Musallam, Khaled M.;
    • Bou‐Fakhredin, Rayan;
    • Cappellini, Maria Domenica;
    • Taher, Ali T.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1356, doi. 10.1002/ajh.24914
    By:
    • Taher, Ali T.;
    • Saliba, Antoine N.;
    • Kuo, Kevin H.;
    • Giardina, Patricia J.;
    • Cohen, Alan R.;
    • Neufeld, Ellis J.;
    • Aydinok, Yesim;
    • Kwiatkowski, Janet L.;
    • Jeglinski, Brenda I.;
    • Pietropaolo, Keith;
    • Berk, Gregory;
    • Viprakasit, Vip
    Publication type:
    Article
    29

    Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1068, doi. 10.1002/ajh.24820
    By:
    • Cappellini, Maria Domenica;
    • Comin-Colet, Josep;
    • de Francisco, Angel;
    • Dignass, Axel;
    • Doehner, Wolfram;
    • S. P. Lam, Carolyn;
    • Macdougall, Iain C.;
    • Rogler, Gerhard;
    • Camaschella, Clara;
    • Kadir, Rezan;
    • Kassebaum, Nicholas J.;
    • Spahn, Donat R.;
    • Taher, Ali T.;
    • Musallam, Khaled M.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 6, p. 503, doi. 10.1002/ajh.23445
    By:
    • Taher, Ali T.;
    • Porter, John B.;
    • Viprakasit, Vip;
    • Kattamis, Antonis;
    • Chuncharunee, Suporn;
    • Sutcharitchan, Pranee;
    • Siritanaratkul, Noppadol;
    • Galanello, Renzo;
    • Karakas, Zeynep;
    • Lawniczek, Tomasz;
    • Habr, Dany;
    • Ros, Jacqueline;
    • Zhang, Yiyun;
    • Cappellini, M. Domenica
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50